IL10 and neoplasm: This shift was associated with decreased pro-inflammatory cytokines (IL-1β, TNF-α) and increased anti-inflammatory cytokines (IL-10, IL-4), along with suppression of tumor-promoting pathways and improved intestinal barrier integrity (Khan et al., 2017).